FPW
AZN icon

Fairvoy Private Wealth’s AstraZeneca AZN Stock Holding History

Fairvoy Private Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$384K Sell
2,027
-16
-0.8% -$3.01K 0.08% 151
2026
Q1 		$403K Sell
2,043
-115
-5% -$22.2K 0.1% 150
2025
Q4 		$397K Hold
2,158
– – 0.09% 134
2025
Q3 		$331K Sell
2,158
-107
-5% -$16.2K 0.08% 150
2025
Q2 		$316K Sell
2,265
-197
-8% -$27.6K 0.08% 142
2025
Q1 		$362K Buy
2,462
+159
+7% +$23K 0.1% 138
2024
Q4 		$302K Buy
+2,303
New +$322K 0.08% 145

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

Fairvoy Private Wealth's AZN Position: Q2 2026 in Review

Fairvoy Private Wealth reduced its AstraZeneca (AZN) stake by 0.78% in Q2 2026, selling an estimated $3.01K and leaving 2,027 shares worth $384K. The position accounts for 0.08% of the portfolio, ranked #151.

Fairvoy Private Wealth first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $403K in Q1 2026. 309 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Fairvoy Private Wealth held 2,027 shares of AstraZeneca worth $384K as of Q2 2026.
  • Fairvoy Private Wealth sold 16 AstraZeneca shares in Q2 2026, an estimated $3.01K.
  • AstraZeneca made up 0.08% of Fairvoy Private Wealth's portfolio in Q2 2026, its #151 holding.
  • Fairvoy Private Wealth first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • Fairvoy Private Wealth's AstraZeneca position peaked at $403K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Fairvoy Private Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.